The University of Chicago Header Logo

Connection

Lilly Immergluck to Clinical Protocols

Back to Details
This is a "connection" page, showing publications Lilly Immergluck has written about Clinical Protocols.
Lilly Immergluck
Connection Strength
0.055
Clinical Protocols
  1. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.